Dade Behring Holdings Company Profile

22:11 EDT 19th June 2018 | BioPortfolio

With 2005 revenue of nearly $1.7 billion, Dade Behring is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of clinical laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients. The businesses from which Dade Behring was formed have been innovators in clinical diagnostics for more than a century. Dade Behring was created in 1997 through the merger of Dade International and the Behring Diagnostics unit of Hoechst AG. Earlier, these companies had combined the diagnostics businesses of the DuPont Company, Syva Company and Baxter Healthcare. Now, Dade Behring ranks as the sixth largest diagnostics company in the world. The company has four core product lines: Chemistry/Immunochemistry, Hemostasis, Microbiology and Infectious Disease Diagnostics. Dade Behring's chemistry/immunochemistry business consists of: Routine Chemistry/Immunochemistry, Cardiac, Plasma Proteins and Drugs-of-Abuse Testing/Therapeutic Drug Monitoring. These products are used to detect and measure substances that may be found in patients' blood, urine or tissue samples. Key products include the following: Routine chemistry/ immunochemistry testing: The Dimension® family of products remain the only systems in the marketplace that integrate highly sensitive immunochemistry testing into the same instrument as routine chemistry testing. This unique product capability can eliminate the need for multiple instruments, simplifying workflow, reducing overall costs, and increasing efficiency in the clinical laboratory. Dade Behring also offers workcells that automate labor-intensive activities by connecting up to six Dimension® analyzers. Cardiac testing: In addition to its broad cardiac test menu on the Dimension® systems, Dade Behring also offers a highly advanced, automated bench-top analyzer called the Stratus® CS Acute Care Diagnostic System. The company is an industry leader in introducing highly-sensitive cardiac marker tests, including Troponin I, high-sensitivity c-reactive protein (hsCRP), and the NT-proBNP tests. Plasma Protein testing: Dade Behring's plasma protein tests diagnose a range of disease and disorders, from heart disease, rheumatic disease, tumors, malnutrition and more through the testing of serum, plasma, urine or cerebral/spinal fluid. Drugs-of-abuse testing (DAT) and therapeutic drug monitoring (TDM): Drugs-of-abuse tests screen for the presence of illicit drugs in a patient's system, while monitoring of therapeutic drugs enable physicians to ensure that therapeutic drugs are present in safe levels in the bloodstream. The Syva® brand remains, after three decades, the leading brand in the drugs-of-abuse and therapeutic drug monitoring market. Dade Behring was a pioneer in the field of Hemostasis (coagulation), and it continues to maintain a global leadership position in this product line. Many of its hemostasis tests measure patients' ability to form and dissolve blood clots, and are generally used before and during surgical procedures or for monitoring coagulation disorders such as hemophilia. Microbiology laboratories use Dade Behring's highly specific MicroScan® products to identify infection-causing bacteria and the minimum dose of antibiotics necessary to treat the infection - critical data in managing patient therapy and health care resources. Dade Behring has taken a leadership role in detecting emerging antimicrobial resistance, and is the only company offering an automated system cleared for improved detection of vancomycin-resistant Staphylococcus aureus (VRSA). Outside of the U.S. market, Dade Behring's (IDD) systems are primarily used for virology testing, including screening for infections such as hepatitis, HIV and sexually transmitted diseases. Dade Behring is headquartered in Deerfield, Illinois, and has operations in 34 countries, employs approximately 6,300 people and serves more than 25,000 customers worldwide.


1717 Deerfield Road
United States of America


Phone: 1 (847) 267-5300

News Articles [440 Associated News Articles listed on BioPortfolio]

CSL Behring achieves new first with Hizentra

The US Food and Drug Administration (FDA) has approved CSL Behring’s Hizentra, the first and only subcutaneous…

US nod for CSL Behring’s Hizentra

US regulators have cleared CSL Behring’s Hizentra for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder affecting the peripheral nerves that c...

Hunt for clues after Miami bridge collapse kills six

Investigators were combing the scene of a footbridge collapse in Miami on Friday to determine how a brand new structure could fail in less than a week, as police said the death toll of six was set to ...

Mosquitoes and ticks are coming to kill us - unless we strike first

A Miami-Dade County mosquito control worker sprays around a home in the Wynwood area of Miami on Monday, Aug. 1, 2016. A Miami-Dade County mosquito control worker sprays around a home in the Wynwood a...

Global Hereditary Angioedema (HAE) Market Spotlight 2018-2028: Shire Sees Another Way To Compete With CSL Behring In HAE With New Version Of Cinryze –

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Hereditary Angioedema (HAE)” report has been added to’s offering. This Market Spotlight report covers...

CSL Behring's Hizentra wins FDA nod for CIDP

The company is hoping the plasma derivative's subcutaneous administration will differentiate it enough to capture market share.

EU, FDA approve CSL's rare disease CIDP drug

The European Commission and the FDA approved CSL Behring's Hizentra human immune globulin as a maintenance therapy for patien -More- 

Sears Holdings Reports Fourth Quarter And Full Year 2017 Results

HOFFMAN ESTATES, Ill., March 14, 2018/PRNewswire/ -- Sears Holdings Corporation ("Holdings," "we," "us," "our," or the "Company") (NASDAQ: SHLD) today announced financial results Read more...

PubMed Articles [13 Associated PubMed Articles listed on BioPortfolio]

Perceptions of Zika Virus Risk during 2016 Outbreak, Miami-Dade County, Florida, USA.

We conducted a survey on Zika virus perceptions and behaviors during the 2016 outbreak in Miami-Dade County, Florida, USA. Among women, Zika knowledge was associated with having a bachelor's degree. A...

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Zika Virus MB16-23 in Mosquitoes, Miami-Dade County, Florida, USA, 2016.

We isolated a strain of Zika virus, MB16-23, from Aedes aegypti mosquitoes collected in Miami Beach, Florida, USA, on September 2, 2016. Phylogenetic analysis suggests that MB16-23 most likely origina...

Economic impacts of urban flooding in South Florida: Potential consequences of managing groundwater to prevent salt water intrusion.

High-value urban zones in coastal South Florida are considered particularly vulnerable to salt water intrusion into the groundwater-based, public water supplies caused by sea level rise (SLR) in combi...

Lovers, enemies, and friends: The complex and coded early history of lesbian comic strip characters.

This article seeks to recuperate four previously unexamined early newspaper comic strip characters that could lay the groundwork for queer comic studies. The titular characters in Lucy and Sophie Say...

Clinical Trials [14 Associated Clinical Trials listed on BioPortfolio]

A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)

As part of CSL Behring Canada's continued commitment to ensuring the safety of the new low volume preparation of Humate-P®, CSL Behring Canada proposes to conduct a prospective, multi-cen...

Preventing Substance Abuse in Hispanic Youth

The focus of this study will be to test the Familias Unidas Intervention program among Hispanic 8th graders in the Miami-Dade County Public School System. This study will contribute to the...

HealthSpark: Health Access for Children in Federally-Subsidized Child Care

HealthSpark is a community-based research network of childcare centers designed to improve the health of children in Miami-Dade County. HealthSpark is the health component of SPARK (Suppo...

Enhancing School Safety Officers' Effectiveness Through Online Professional and Job Embedded Coaching

The University of Florida's (UF) Lastinger Center for Learning, in partnership with the UF Psychology Department, have been funded by the National Institute of Justice to advance the skill...

The Effect of Human Albumin on Coagulation Competence and Hemorrhage

In a randomized clinical trial, the purpose is to investigate if perioperative coagulation and hemorrhage is influenced by colloid or crystalloid.

Companies [460 Associated Companies listed on BioPortfolio]

Dade Behring's chemistry

With 2005 revenue of nearly $1.7 billion, Dade Behring is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to mee...

Dade Behring Holdings

With 2005 revenue of nearly $1.7 billion, Dade Behring is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to mee...

CSL Behring

CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the com...

CSL Behring Canada

Berinert is the only HAE therapy available in Canada. It offers over 30 years of international clinical use experience with more than 400,000 treatments given in Germany, Austria, Switzerland, Japan, ...

ZLB Behring LLC

ZLB Behring is one of the world’s leading pharmaceutical companies specializing in the manufacture of plasma products. Its comprehensive line of therapies include products for the treatment of hemop...

More Information about "Dade Behring Holdings" on BioPortfolio

We have published hundreds of Dade Behring Holdings news stories on BioPortfolio along with dozens of Dade Behring Holdings Clinical Trials and PubMed Articles about Dade Behring Holdings for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dade Behring Holdings Companies in our database. You can also find out about relevant Dade Behring Holdings Drugs and Medications on this site too.

Quick Search


Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Corporate Database Quicklinks

Searches Linking to this Company Record